Products mentioned by Kate Haviland
Products Kate Haviland has mentioned or recommended across podcast appearances.
SignalCast may earn a small commission on purchases through these links — at no extra cost to you. As an Amazon Associate we earn from qualifying purchases.
Blue808
Authorby Blueprint Medicines
“Blueprint's $9.1 billion Sanofi acquisition originated as a partnership discussion around pipeline asset Blue808, a wild-type KIT inhibitor targeting broad type-2 inflammation diseases like asthma and chronic urticaria.”
Avakit
Authorby Blueprint Medicines
“When Blueprint's drug Avakit showed significant mast cell depletion at just 30mg in advanced systemic mastocytosis patients — far below the 200mg cancer dose — the team recognized a chronic disease opportunity.”